Walleye Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.26M Buy
67,268
+66,595
+9,895% +$5.37M 0.02% 792
2026
Q1
$58.3K Sell
673
-468,117
-100% -$44.8M ﹤0.01% 3854
2025
Q4
$45M Buy
+468,790
New +$45.5M 0.14% 77
2025
Q3
Sell
-19,493
Closed -$1.79M 4869
2025
Q2
$1.7M Buy
+19,493
New +$1.65M 0.01% 1649
2025
Q1
Sell
-16,909
Closed -$1.51M 4759
2024
Q4
$1.35M Buy
16,909
+11,375
+206% +$985K ﹤0.01% 2119
2024
Q3
$498K Sell
5,534
-46,467
-89% -$3.91M ﹤0.01% 3303
2024
Q2
$4.09M Sell
52,001
-143,987
-73% -$11.8M 0.01% 1444
2024
Q1
$17.1M Buy
195,988
+155,474
+384% +$13.3M 0.03% 511
2023
Q4
$3.34M Sell
40,514
-14,960
-27% -$1.14M 0.01% 1386
2023
Q3
$4.35M Buy
+55,474
New +$4.64M 0.01% 1136
2023
Q1
Sell
-14,124
Closed -$1.15M 4200
2022
Q4
$1.1M Buy
+14,124
New +$1.14M 0.02% 945
2022
Q1
Sell
-81,311
Closed -$8.41M 2463
2021
Q4
$8.41M Buy
+81,311
New +$9.42M 0.26% 79
2018
Q3
$285K Buy
+2,901
New +$268K 0.13% 183

Other funds holding MDT

Walleye Capital's MDT Position: Q2 2026 in Review

Walleye Capital increased its Medtronic (MDT) stake by 9,895% in Q2 2026, buying an estimated $5.37M and bringing the position to 67,268 shares worth $5.26M. The position accounts for 0.02% of the portfolio, ranked #792.

Walleye Capital first reported a position in MDT in Q3 2018 and has held it in 13 quarters since. The position peaked at $45M in Q4 2025. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Walleye Capital held 67,268 shares of Medtronic worth $5.26M as of Q2 2026.
  • Walleye Capital bought 66,595 Medtronic shares in Q2 2026, an estimated $5.37M.
  • Medtronic made up 0.02% of Walleye Capital's portfolio in Q2 2026, its #792 holding.
  • Walleye Capital first reported a position in Medtronic in Q3 2018 and has held it in 13 quarters since.
  • Walleye Capital's Medtronic position peaked at $45M in Q4 2025.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.